跳至主要内容
临床试验/NCT03247764
NCT03247764Unknown不适用

A Registration Study on Drug Treatment for Comorbid Depression in Patients With Epilepsy in East China

Shanghai Zhongshan Hospital7 个研究点 分布在 1 个国家目标入组 320 人开始时间: 2018年2月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
320
试验地点
7
主要终点
the drug treatment rate of depression in patients with epilepsy

研究概览

简要总结

The aim of this study is to register the drug treatment of depression in patients with epilepsy in East China.

详细描述

As the treatment rate for depression in epilepsy is unclear and the discordant voice of choosing antidepressants for most doctors, this prospective observational cohort study was designed to better understand the current situation of drug treatments in patients with the comorbidity of epilepsy and depression in East China. The secondary outcome was to investigate whether baseline depressive symptoms had an influence on seizure-control in patients with epilepsy at follow-up.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

the drug treatment rate of depression in patients with epilepsy

时间窗: 6 months

the drug treatment rate at baseline and 6 months at follow-up

次要结局

  • the influence of depression on seizure-control(6 months)

研究者

发起方
Shanghai Zhongshan Hospital
申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验

A Registration Study on Depression in Patients With... | 临床试验